Tech Center 1600 • Art Units: 1654 1658 1675 1699
This examiner grants 50% of resolved cases
Koyeli Banerjee operates within Tech Center 1600 and Art Unit 1654. The examiner has 2 resolved cases, which result in an allowance rate of 50.0%. This rate provides a starting point for understanding the likelihood of success in this art unit. The interview lift is currently 0.0%, indicating that interviews have not yet shown a statistical impact on the 50.0% allowance rate. With only 2 cases resolved, these figures represent an early stage of data collection.
The median days to allowance for these applications is 1148. This pendency of 1148 days is the primary timeline metric available for Art Unit 1654 in this profile. Practitioners should note that the 0.0% interview lift and 50.0% allowance rate are derived from a very small sample of 2 cases. As the examiner resolves more applications in Tech Center 1600, these performance indicators may evolve. For now, the 1148 days median serves as the expected duration for reaching a resolution.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18735130 | METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTIVE GROUP-FORMING REAGENT, AND SUBSTITUTED BENZYL COMPOUND | Non-Final OA | FUJIFILM Corporation |
| 18742659 | RNA-Dependent RNA Polymerase Inhibitory Compounds, Uses in Managing Viral Infections, and Pharmaceutical Compositions | Non-Final OA | Emory University |
| 18359793 | Novel Peptide Carrier Compositions | Non-Final OA | The Regents of the University of Colorado, A Body Corporate |
| 18728874 | BONE TARGETED TREATMENT IN OSTEOGENESIS IMPERFECTA | Non-Final OA | PURDUE RESEARCH FOUNDATION |
| 18814954 | Reagents and methods for treating bacterial infection | Non-Final OA | University of Washington |
| 18554285 | PEPTIDE-SMALL INTERFERING RNA-HYALURONIC ACID NANOPARTICLES AND METHODS OF USE THEREOF | Non-Final OA | UNIVERSITY OF SOUTH FLORIDA |
| 18574161 | METHOD OF RECONSTITUTING LYOPHILIZED FORMULATION | Non-Final OA | AMGEN INC. |
| 18251553 | MATERIALS AND METHODS FOR PROTEIN PROCESSING | Final Rejection | AMGEN INC. |
| 18695526 | PEPTIDE HAVING ACTIVITY OF PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH AND USE THEREOF | Non-Final OA | CAREGEN CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy